1-3 of 3
T.M. de Witte, MD, PhD
Close
Sort by
Journal Articles

Aberrant Expression in Human Epithelial Cancers of the P2X5-Encoded Minor Histocompatibility Antigen LRH-1: Implications for Graft-Versus-Tumor Immunity Against Solid Tumors.

Harry Dolstra, PhD, Henriette Levenga, MD, Ingrid Overes, MSc, Johanna C.M. Vos, BSc, Agnes van Horssen-Zoetbrood, BSc, Robbert van der Voort, PhD, Pieter de Mulder, MD, PhD, T.M. de Witte, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 1795.
https://doi.org/10.1182/blood.V110.11.1795.1795
Published: 2007
Journal Articles

Human CD34+ Myeloid Leukemic Progenitor Cells Are Susceptible to Lysis by Minor Histocompatibility Antigen LRH-1-Specific Cytotoxic T Lymphocytes.

Harry Dolstra, PhD, Ingrid Overes, Inge Jedema, PhD, Annemieke Vos, Agnes van Horssen-Zoetbrood, Wieger Norde, Robbert van der Voort, PhD, J.H. Frederik Falkenburg, MD, PhD, Anton V. Schattenberg, MD, PhD, T.M. de Witte, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 134.
https://doi.org/10.1182/blood.V108.11.134.134
Published: 2006
Journal Articles

Vaccination with Host Dendritic Cells Induces Graft-Versus-Leukemia Responses without Severe Graft-Versus-Host Disease in a Preclinical Mouse Model for Allogeneic Stem Cell Transplantation.

Robbert van der Voort, PhD, Jurjen Ruben, BSc, Annemieke Vos, BSc, Marielle Philippens, MD, T.M. de Witte, MD, PhD, Harry Dolstra, PhD
Journal: Blood
Blood (2006) 108 (11): 3239.
https://doi.org/10.1182/blood.V108.11.3239.3239
Published: 2006